We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.62B
AUM Growth
+$482M
Cap. Flow
+$328M
Cap. Flow %
3.41%
Top 10 Hldgs %
35.81%
Holding
1,132
New
163
Increased
147
Reduced
109
Closed
164
Avg Time Held Equity + Options
2.6 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
2.6 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Top Buys

Rank Stock Value
1
ACC
American Campus Communities, Inc.
ACC
+$454M
2
SAIL icon
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
+$312M
3
CDK
CDK Global, Inc.
CDK
+$286M
4
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$248M
5
MNDT
Mandiant, Inc. Common Stock
MNDT
+$220M

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$829M
2
MIME
Mimecast Limited
MIME
+$351M
3
PLAN
Anaplan, Inc.
PLAN
+$325M
4
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
+$260M
5
VNE
Veoneer, Inc.
VNE
+$240M

Sector Composition

Rank Sector Weight
1 Technology 27.77%
2 Financials 20.95%
3 Industrials 11.05%
4 Real Estate 10.82%
5 Healthcare 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PATH icon
651
UiPath
PATH
$6.91B
$1.82M 0.02%
100,000
+30,000
+43% +$561K
2021 Q3
3 quarters
BBBY
652
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
$1.81M 0.02%
234,200
– –
2022 Q1
1 quarter
HHLA
653
DELISTED
HH&L Acquisition Co.
HHLA
$1.81M 0.02%
184,388
– –
2021 Q3
3 quarters
HORI
654
DELISTED
Emerging Markets Horizon Corp. Class A Ordinary Shares
HORI
$1.78M 0.02%
180,162
– –
2022 Q1
1 quarter
BRIV
655
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$1.77M 0.02%
181,701
– –
2021 Q3
3 quarters
DY icon
656
Dycom Industries
DY
$8.13B
$1.76M 0.02%
+18,955
New +$1.69M
2022 Q2
0 quarters
PTGX icon
657
Protagonist Therapeutics
PTGX
$8.96B
$1.74M 0.02%
219,820
+179,820
+450% +$2.17M
2022 Q1
1 quarter
SKYA icon
658
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$1.74M 0.02%
178,196
– –
2021 Q3
3 quarters
NRG icon
659
NRG Energy
NRG
$22.5B
$1.73M 0.02%
45,323
-23,655
-34% -$967K
2022 Q1
1 quarter
ADPT icon
660
Adaptive Biotechnologies
ADPT
$4.03B
$1.73M 0.02%
213,490
+125,490
+143% +$1.1M
2022 Q1
1 quarter
ENDP
661
PUT
DELISTED
Endo International plc
ENDP
$1.71M 0.02%
447,500
– –
2021 Q2
4 quarters
CORS
662
DELISTED
Corsair Partnering Corporation
CORS
$1.71M 0.02%
176,344
– –
2021 Q3
3 quarters
VSTM icon
663
Verastem
VSTM
$675M
$1.66M 0.02%
118,915
+65,582
+123% +$1.04M
2022 Q1
1 quarter
AUTL icon
664
Autolus Therapeutics
AUTL
$431M
$1.65M 0.02%
584,246
+384,246
+192% +$1.17M
2022 Q1
1 quarter
O icon
665
Realty Income
O
$52B
$1.65M 0.02%
24,121
-31,679
-57% -$2.18M
2021 Q4
2 quarters
ANAB icon
666
AnaptysBio
ANAB
$1.36B
$1.64M 0.02%
80,966
+35,966
+80% +$797K
2022 Q1
1 quarter
MRUS icon
667
DELISTED
Merus
MRUS
$1.63M 0.02%
72,116
+27,116
+60% +$566K
2022 Q1
1 quarter
CRNX icon
668
DELISTED
Crinetics Pharmaceuticals
CRNX
$1.63M 0.02%
87,460
+22,460
+35% +$448K
2022 Q1
1 quarter
ORIC icon
669
Oric Pharmaceuticals
ORIC
$1.17B
$1.62M 0.02%
+361,055
New +$1.44M
2022 Q2
0 quarters
VRTX icon
670
Vertex Pharmaceuticals
VRTX
$123B
$1.6M 0.02%
+5,690
New +$1.52M
2022 Q2
0 quarters
ESTA icon
671
Establishment Labs
ESTA
$1.74B
$1.6M 0.02%
29,426
+10,426
+55% +$662K
2022 Q1
1 quarter
REVE
672
DELISTED
Alpine Acquisition Corp
REVE
$1.6M 0.02%
157,507
– –
2021 Q4
2 quarters
RIG icon
673
PUT
Transocean
RIG
$6.31B
$1.59M 0.02%
1,967,700
– –
2018 Q2
16 quarters
KROS icon
674
Keros Therapeutics
KROS
$223M
$1.58M 0.02%
57,321
+32,321
+129% +$1.42M
2022 Q1
1 quarter
ACRS icon
675
Aclaris Therapeutics
ACRS
$511M
$1.58M 0.02%
113,426
+59,924
+112% +$840K
2022 Q1
1 quarter
25 26
27
28 29

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2022 Portfolio in Review

As of Q2 2022, UBS O'Connor held 1,132 positions worth $9.62B, up 5.3% from $9.14B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

UBS O'Connor deployed $328M of net new capital in Q2 2022, opening 163 new positions and adding to 147 existing holdings. Its largest new stake was American Campus Communities, Inc.: 7,174,697 shares worth $463M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Occidental Petroleum Corp Warrants, an estimated $15.7M trimmed.

  • UBS O'Connor's largest Q2 2022 buy was American Campus Communities, Inc.: 7,174,697 shares worth $463M.
  • UBS O'Connor added most to Mandiant, Inc. Common Stock in Q2 2022, an estimated $220M increase.
  • UBS O'Connor's biggest Q2 2022 reduction was Occidental Petroleum Corp Warrants, cutting an estimated $15.7M.
  • UBS O'Connor fully exited Cerner Corp in Q2 2022, selling an estimated $829M.
  • UBS O'Connor's ten largest holdings make up 36% of its $9.62B portfolio in Q2 2022.
  • UBS O'Connor opened 163 new positions and closed 164 in Q2 2022.
  • UBS O'Connor's portfolio value rose 5.3% quarter-over-quarter to $9.62B.

Based on UBS O'Connor's 13F filing for Q2 2022, filed 12 Aug 2022.